DSLD label record: FINAFLEX Creatine Unflavored powder
This DSLD record lists FINAFLEX Creatine Unflavored as a powder whose label declares 5 grams of creatine monohydrate per labelled serving. It is a label snapshot only, not evidence of efficacy, safety or approval. [1]
Automatic summary · not editorially reviewed
FROM THE ORIGINAL LABEL
A closer look at the product
- Pack contents
- 5.3 Ounce(s) · 150 Gram(s)
- Label serving
- 5–10 Gram(s)
- Servings per container
- 30
- Barcode / SKU
- 8 10020 72250 5
Ingredients & declared amounts1
Amounts from the label, per specified serving. These are manufacturer declarations, not a personal dosage recommendation.
| Ingredient | Amount | Per label serving |
|---|---|---|
| Creatine Monohydrate | 5 Gram(s) | 5 Gram(s) |
Source: National Institutes of Health, Office of Dietary Supplements · Dietary Supplement Label Database. Label snapshot; packaging and formulation may have changed.
The key findings
The source at a glance
- Brand
- FINAFLEX
- Form
- Powder
- Pack contents
- 5.3 Ounce(s) · 150 Gram(s)
- Label serving
- 5–10 Gram(s)
- Ingredients listed
- Creatine Monohydrate
- Record type / format
- Dietary supplement label/database record
- Scope / context
- FINAFLEX Creatine Unflavored, a powder product as described in DSLD record 333665
- Summary based on
- Product label / database record
FINAFLEX powder record in the NIH DSLD
The source is record 333665 in the NIH Office of Dietary Supplements Dietary Supplement Label Database. The declared product label name is Creatine Unflavored and the declared brand is FINAFLEX. The label states the physical form as powder, and DSLD places the product in the category Non-Nutrient/Non-Botanical. The record notes that the label entered DSLD on 2025-07-24, which is not a product launch date.
Supporting source [1]
Declared ingredient: 5 g creatine monohydrate
The only declared ingredient in this record is creatine monohydrate, listed at 5 grams per labelled serving. This amount is a label fact, not personal dosing advice. The record supplies no independent product testing, no price and no batch certificate.
Supporting source [1]
What this label snapshot does not establish
The record describes label declarations only. Inclusion in DSLD does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. The source does not describe any study, population or outcome, so it cannot support claims about effects in people.
Supporting source [1]
How to interpret this
Product label record; not evidence of efficacy or approval. The record describes label declarations only and supplies no independent testing, price or batch certificate.
Based on a product label or database record. This does not establish effectiveness, independent batch testing, approval or current availability.
Source & supporting passages
FINAFLEX · dsld.od.nih.gov
